89BIO INC (ETNB) Stock Analyst Earnings Estimates
NASDAQ:ETNB - Nasdaq - US2825591033 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A 1,067.45% | N/A 596.08% | N/A 322.73% | N/A 85.76% | N/A 30.19% | N/A 13.42% | ||||||||
| EBITDA YoY % growth | -15.15M | -26.62M -75.71% | -49.3M -85.20% | -89.66M -81.87% | -102.18M -13.96% | -151.154M -47.93% | -384.618M -154.45% | N/A 15.61% | N/A -11.80% | N/A -10.56% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -15.16M | -26.64M -75.73% | -49.36M -85.29% | -89.74M -81.81% | -102.25M -13.94% | -151.204M -47.88% | -384.656M -154.40% | N/A 11.70% | N/A -13.65% | N/A -1.85% | N/A 14.10% | N/A 156.45% | N/A 314.32% | N/A 85.59% | N/A 30.56% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | -3.10 78.22% | -4.48 -44.52% | -3.54 20.98% | -2.01 43.22% | -3.43 -70.65% | N/A 36.56% | N/A -5.27% | N/A 5.09% | N/A 43.47% | N/A 193.98% | N/A 237.75% | N/A -51.90% | N/A 66.30% |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.50 -3.94% | -0.53 61.68% | -0.58 43.16% | -0.62 -26.29% |
| Revenue Q2Q % growth | ||||
| EBITDA Q2Q % growth | -75.317M -41.00% | -78.308M 48.45% | -91.312M 25.13% | N/A |
| EBIT Q2Q % growth | -80.599M -50.83% | -85.233M 43.90% | -93.028M 23.75% | -104.664M -37.88% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -0.49 9.26% | -0.51 | 0.02 | 3.43% |
| Q4 2024 Q2Q % growth | -1.02 -104.00% | -0.79 | -0.23 | -29.63% |
| Q3 2024 Q2Q % growth | -1.39 -208.89% | -0.65 | -0.74 | -112.45% |
| Q2 2024 Q2Q % growth | -0.48 7.69% | -0.58 | 0.10 | 17.40% |
| Q1 2024 Q2Q % growth | -0.54 | -0.47 | -0.07 | -14.78% |
| Q4 2023 Q2Q % growth | -0.50 -4.17% | -0.50 | 0.00 | 0.97% |
| Q3 2023 Q2Q % growth | -0.45 21.05% | -0.54 | 0.09 | 16.76% |
| Q2 2023 Q2Q % growth | -0.52 57.72% | -0.42 | -0.10 | -23.91% |
| Q1 2023 Q2Q % growth | -0.54 57.14% | -0.53 | -0.01 | -1.48% |
| Q4 2022 Q2Q % growth | -0.48 63.08% | -0.70 | 0.22 | 31.43% |
| Q3 2022 Q2Q % growth | -0.57 59.57% | -0.81 | 0.24 | 29.93% |
| Q2 2022 Q2Q % growth | -1.23 -19.42% | -1.07 | -0.16 | -14.52% |
| Q1 2022 Q2Q % growth | -1.26 -70.27% | -1.32 | 0.06 | 4.45% |
| Q4 2021 Q2Q % growth | -1.30 -106.35% | -1.33 | 0.03 | 2.58% |
| Q3 2021 Q2Q % growth | -1.41 -63.95% | -1.08 | -0.33 | -30.92% |
| Q2 2021 Q2Q % growth | -1.03 -21.18% | -0.86 | -0.17 | -20.42% |
| Q1 2021 Q2Q % growth | -0.74 2.63% | -0.71 | -0.03 | -4.69% |
| Q4 2020 Q2Q % growth | -0.63 75.58% | -0.89 | 0.26 | 29.01% |
| Q3 2020 Q2Q % growth | -0.86 97.19% | -0.86 | 0.00 | -0.39% |
| Q2 2020 Q2Q % growth | -0.85 | -0.85 | 0.00 | 0.20% |
| Q1 2020 Q2Q % growth | -0.76 | -0.88 | 0.12 | 13.69% |
| Q4 2019 Q2Q % growth | -2.58 | -0.96 | -1.62 | -168.37% |
| Q3 2019 Q2Q % growth | -30.63 | -1.23 | -29.40 | -2,395.53% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 546.424K | -546.424K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -3.04% | 0% | -4.81% |
| Revenue | N/A | N/A | N/A | N/A |